IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Players Observe High Demand for TNF Inhibitors, Notes TMR Report

News provided by

Jul 20, 2022, 07:30 ET

The IBD (ulcerative colitis and Crohn's disease) treatment market is projected to exceed a value of US$ 34.22 Bn by 2031
Increase in cases of ulcerative colitis globally is leading to growth opportunities in IBD (ulcerative colitis and Crohn's disease) treatment market

WILMINGTON, Del., July 20, 2022 /PRNewswire/ -- A research report by Transparency Market Research (TMR) expects the global IBD treatment market to develop at a CAGR of 6.8% during the forecast period from 2022 to 2031.

Several IBD (ulcerative colitis and Crohn's disease) treatment manufacturers are offering attractive reimbursement plans in order to support the healthcare spending. Such initiatives are expected to impact positively on the sentiments of patients pertaining to the effectual treatment of this disease. This factor, in turn, is likely to boost the demand for IBD (ulcerative colitis and Crohn's disease) treatment solutions in the forthcoming years.

Physicians across the globe are inclining toward prescribing TNF inhibitors for the treatment of moderate to critical ulcerative colitis. As a result, there has been increase in the investments in R&Ds focused on TNF inhibitors, note analysts of a TMR report on the IBD (ulcerative colitis and Crohn's disease) treatment market.

Request Brochure of IBD Treatment Market Research Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1473

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market: Key Findings

The number of the global patients suffering from inflammatory bowel disease (IBD) is being increasing around the world in the recent years. This factor is leading to notable growth prospects for IBD (Ulcerative Colitis and Crohn's Disease) treatment market.
The global IBD (ulcerative colitis and Crohn's disease) treatment market is being driven by factors such as increase in the approvals for novel biologic drugs for IBD and rise in the use of IBD treatment solutions in several emerging economies. Thus, the IBD (ulcerative colitis and Crohn's disease) treatment market is expected to be valued at over US$ 34.22 Bn by 2031.

Request for Analysis of COVID-19 Impact on IBD Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1473

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market: Growth Boosters

Rise in the prevalence of ulcerative colitis across many developed and developing nations is boosting the sales growth in the IBD (ulcerative colitis and Crohn's disease) treatment market
Surge in the adoption of TNF inhibitors owing to their high level of efficacy, improved therapeutic outcomes, and safety are boosting the sales growth in the market
Increasing inclination among people toward using biosimilar or biologic drugs is foreseen to demand opportunities in the market for IBD (ulcerative colitis and Crohn's disease) treatment

Get Exclusive PDF Sample Copy of IBD Treatment Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1473

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market: Regional Analysis

The IBD (ulcerative colitis and Crohn's disease) treatment market in North America is expected to maintain its dominating position during the forecast period owing to a rise in the prevalence of Crohn's disease and ulcerative colitis in Canada and the U.S. Moreover, the regional market is anticipated to expand at prominent pace owing to the presence of sturdy healthcare infrastructure and increase in the incidences of lifestyle-related disorders among the people from North America.
The market in Latin America and Middle East & Africa is expected to expand at notable CAGR during the forecast period owing to an increase in the number of patients with IBD in the regions. Moreover, the market in these regions is anticipated to expand owing to rise in the focus of regional market players on the development of next-gen therapeutics.

Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1473

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market: Key Players

Some of the key players profiled in the report are:

Janssen Biotech, Inc. (Johnson & Johnson)
Pfizer, Inc.
Allergan plc
Health Companies, Inc.
AbbVie, Inc.
Takeda Pharmaceutical Company Limited
UCB, Inc.
Novartis AG
Biogen, Inc.

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Segmentation

Drug Class

TNF Inhibitors
Aminosalicylates
Integrin Antagonists
Corticosteroids
Others

Disease Indication

Ulcerative Colitis
Crohn's Disease

Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regions Covered

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Addiction Treatment Market: The global addiction treatment market was valued at US$ 6.2 Bn in 2019 and is anticipated to expand at a CAGR of ~6% from 2020 to 2030.

Bruise Treatment Market: The global bruise treatment market is anticipated to reach more than US$ 444 Mn by the end of 2031. The global market is projected to expand at a CAGR of 3.5% from 2022 to 2031.

Venous Diseases Treatment Market: Rise in awareness about deep vein thrombosis treatment, chronic venous occlusions treatment, venous insufficiency treatment, and leg ulcer treatment; and growth in number of product approvals are driving the market.

Pressure Ulcers Treatment Market: Rise in prevalence of pressure ulcers, increase in prevalence of chronic diseases, and technological advancements in wound care are anticipated to propel the global pressure ulcers treatment market during the forecast period.

Substance Abuse Treatment Market: Rise in awareness about the negative effects of substance abuse, introduction of new programs, and increase in number of rehabilitation centers globally are expected to contribute to the growth of the global market.

Chronic Pelvic Pain Treatment Market: Growth in adoption of new treatment procedures such as acupuncture, chiropractic care, biofeedback therapy, and behavioral therapy is projected to drive the global chronic pelvic pain treatment market.

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Rise in adoption of digital inhalers and triple therapy treatment options is expected to create incremental opportunities for manufacturers in the COPD treatment market during the forecast period.

Psoriasis Treatment Market: Rise in the psoriasis patient pool, approval of new biologic drugs for psoriasis, novel drug pipeline, and increase in access to psoriasis treatment in developing countries are anticipated to propel the global psoriasis treatment market.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]